Weitzman, E. R., Alegria, M., Caplan, A., Dowling, D., Evans, J., Fisher, C. E., Jordan, A., Kossowsky, J., Landau, M., Larson, H., Levy, O., Levy, S., Mnookin, S., Reif, S., Ross, J., & Sherman, A. C. (2025). Social complexity of a fentanyl vaccine to prevent opioid overdose conference proceedings: Radcliffe Institute for Advanced Study conference proceedings. Vaccine, 44, 126324. https://doi.org/10.1016/j.vaccine.2024.126324

Krause, K. D., D’Avanzo, P. A., Karr, A. G., Rhem, C., & Halkitis, P. N. (2024). Vaccination uptake in LGBTQ adults in two US states: Findings from the QVax study. Vaccine, 42(26), 126320. https://doi.org/10.1016/j.vaccine.2024.126320

Chang, J. Y., Chang, M., Huang, S., Bosco, J., McNairy, M., Tukuru, S., Wu, Y. H., Kunkel-Jure, J., Weidler, J., Goodman, T., Dorr, C., Roberts, R., Gray, B., Zucker, J., Sobieszczyk, M. E., & Castor, D. (2024). COVID-19 vaccine uptake in a predominantly minoritized cohort hospitalized during the early pandemic in New York City. Vaccine, 42(26), 126260. https://doi.org/10.1016/j.vaccine.2024.126260

Kim, S., Choi, J.-K., Suh, J., Park, S. H., & Lee, J. (2024). The epidemiologic and economic impact of varicella and herpes zoster vaccination in South Korea: A mathematical modelling study. Vaccine, 42(19), 4046–4055. https://doi.org/10.1016/j.vaccine.2024.05.016

Kainth, M. K., Sembajwe, G. N., Ahn, H., Qian, M., Carrington, M., Armellino, D., & Jan, S. (2024). Despite mandated primary series, health care personnel still hesitant about COVID-19 vaccine and immunizing children. Vaccine, 42(12), 3122–3133. https://doi.org/10.1016/j.vaccine.2024.04.028

Yu, J., Sreenivasan, C., Sheng, Z., Zhai, S.-L., Wollman, J. W., Luo, S., Huang, C., Gao, R., Wang, Z., Kaushik, R. S., Christopher-Hennings, J., Nelson, E., Hause, B. M., Li, F., & Wang, D. (2023). A recombinant chimeric influenza virus vaccine expressing the consensus H3 hemagglutinin elicits broad hemagglutination inhibition antibodies against divergent swine H3N2 influenza viruses. Vaccine, 41(42), 6318–6326. https://doi.org/10.1016/j.vaccine.2023.09.007

Tieu, H.-V., Karuna, S., Huang, Y., Sobieszczyk, M. E., Zheng, H., Tomaras, G. D., Montefiori, D. C., Shen, M., DeRosa, S., Cohen, K., Isaacs, M. B., Regenold, S., Heptinstall, J., Seaton, K. E., Sawant, S., Furch, B., Pensiero, M., Corey, L., & Bar, K. J. (2023). Safety and immunogenicity of a recombinant oligomeric gp145 subtype C Env protein (gp145 C.6980) HIV vaccine candidate in healthy, HIV-1–uninfected adult participants in the US. Vaccine, 41(42), 6309–6317. https://doi.org/10.1016/j.vaccine.2023.07.046

Embi, P. J., Levy, M. E., Patel, P., DeSilva, M. B., Gaglani, M., Dascomb, K., Dunne, M. M., Klein, N. P., Ong, T. C., Grannis, S. J., Natarajan, K., Yang, D.-H., Stenehjem, E., Zerbo, O., McEvoy, C., Rao, S., Thompson, M. G., Konatham, D., Irving, S. A., … Naleway, A. L. (2023). Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021. Vaccine, 41(37), 5424–5434. https://doi.org/10.1016/j.vaccine.2023.05.038

Turley, C. B., Tables, L., Fuller, T., Sanders, L. J., Scott, H., Moodley, A., Woodward Davis, A., Leav, B., Miller, J., Schoemaker, K., Vandebosch, A., Sadoff, J., Woo, W., Cho, I., Dunkle, L. M., Li, S., van der Laan, L., Gilbert, P. B., Follmann, D., … Luedtke, A. (2023). Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials. Vaccine, 41(33), 4899–4906. https://doi.org/10.1016/j.vaccine.2023.06.066

Rubin Thompson, L. J., Grubo, M., Veller, M., Badenhorst, R. H., Nott, J., Debruyne, L., Makadzange, T., Nicolaou, S., Stanberry, L., Sall, A., & James, W. G. (2023). Building global vaccine manufacturing capacity: Spotlight on Africa. Vaccine, 41(27), 4050–4056. https://doi.org/10.1016/j.vaccine.2023.05.009

Rodriguez, D. M., Major, C. G., Sánchez-González, L., Jones, E., Delorey, M. J., Alonso, C., Rivera-Amill, V., Paz-Bailey, G., & Adams, L. E. (2023). Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico. Vaccine, 41(24), 3627–3635. https://doi.org/10.1016/j.vaccine.2023.04.081

Harris, J. N., Mauro, C. M., Morgan, T. L., de Roche, A., Zimet, G. D., & Rosenthal, S. L. (2023). Factors impacting parental uptake of COVID-19 vaccination for U.S. Children ages 5–17. Vaccine, 41(20), 3151–3155. https://doi.org/10.1016/j.vaccine.2023.04.001

Chen, S., Gao, S., Li, J., Li, J., & Duan, Z. (2023). Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China. Vaccine, 41(2), 547–554. https://doi.org/10.1016/j.vaccine.2022.11.074

Patel, K. M., Shafiq, M., Malik, A. A., Cobanoglu, A., Klotz, M., Eric Humphries, J., Lee, A., Murray, T., Wilkinson, D., Yildirim, I., Elharake, J. A., Diaz, R., Rojas, R., Kuperwajs Cohen, A., Omer, S. B., & Gilliam, W. S. (2022). Relationship between the use of nonpharmaceutical interventions and COVID-19 vaccination among U.S. child care providers: A prospective cohort study. Vaccine, 40(31), 4098–4104. https://doi.org/10.1016/j.vaccine.2022.05.064

McAndrew, T., Cambeiro, J., & Besiroglu, T. (2022). Aggregating human judgment probabilistic predictions of the safety, efficacy, and timing of a COVID-19 vaccine. Vaccine, 40(15), 2331–2341. https://doi.org/10.1016/j.vaccine.2022.02.054

Teasdale, C. A., Borrell, L. N., Shen, Y., Kimball, S., Rinke, M. L., Fleary, S. A., & Nash, D. (2021). Parental plans to vaccinate children for COVID-19 in New York city. Vaccine, 39(36), 5082–5086. https://doi.org/10.1016/j.vaccine.2021.07.058